Middle East and Africa Irritable Bowel Syndrome (IBS) Diagnostics Market

Market Introduction

Irritable bowel syndrome (IBS) is defined as gastro-intestinal disorder causing discomfort in the stomach, along with wind, diarrhoea and constipation. IBS can develop after a severe session of diarrhea (gastroenteritis) caused by bacteria or a virus. People exposed to stressful events, especially in childhood, tend to have more symptoms of IBS. IBS diagnostics is done through medical history, physical exam and imaging tests.

Middle East and Africa Irritable Bowel Syndrome (IBS) Diagnostics Strategic Insights

Strategic insights for the Middle East and Africa Irritable Bowel Syndrome (IBS) Diagnostics provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Middle East and Africa Irritable Bowel Syndrome (IBS) Diagnostics Report Scope

Middle East and Africa Irritable Bowel Syndrome (IBS) Diagnostics Regional Insights

The geographic scope of the Middle East and Africa Irritable Bowel Syndrome (IBS) Diagnostics refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

The Middle East and Africa irritable bowel syndrome (IBS) diagnostics market is expected to reach US$ 156.79 million by 2028 from US$ 117.32 million in 2020; it is estimated to grow at a CAGR of 3.8% from 2021 to 2028. The growth of the market is determined due to some of the key driving factors, such as increasing prevalence of irritable bowel syndrome and associated conditions and advancements in diagnostics of syndrome. On the other hand, challenges in diagnosis of IBS are likely to restraint the growth of market during the forecast years.

Key Market Segments

Based on the diagnosis, the Middle East and Africa irritable bowel syndrome (IBS) diagnostics market was segmented into laboratory tests and imaging tests. In 2020, the laboratory tests segment held a larger share of the market and is expected to grow at a faster rate during the coming years.

Based on indication, the Middle East and Africa irritable bowel syndrome (IBS) diagnostics market is segmented into pain and cramping, diarrhea, constipation, and alternating constipation & diarrhea. The pain and cramping segment held the largest share of the market in 2020 and is anticipated to register the highest CAGR in the market during the forecast period.

Major Sources and Companies Listed

A few of the primary and secondary sources associated with this report on the Middle East and Africa irritable bowel syndrome (IBS) diagnostics market are Medically Associated Science and Technology (MAST), Centers for Disease Control and Prevention (CDC) and International Foundation for Gastrointestinal Disorders (IFFGD).

Reasons to buy the report

• Determine prospective investment areas based on a detailed trend analysis Middle East and Africa irritable bowel syndrome (IBS) diagnostics market over the next years.
• Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
• Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
• Identify the major channels driving the Middle East and Africa irritable bowel syndrome (IBS) diagnostics market, providing a clear picture of future opportunities that will help Analyze, resulting in revenue expansion.
• Channelize resources by focusing on the ongoing programs undertaken by the different countries within the Middle East and Africa irritable bowel syndrome (IBS) diagnostics market.

MIDDLE EAST AND AFRICA NORTH AMERICA IRRITABLE BOWEL SYNDROME (IBS) DIAGNOSTICS MARKET SEGMENTATION

By Diagnosis

• Laboratory Tests
  • Lactose Intolerance Tests
  • Breath Test for Bacterial Overgrowth
  • Stool Tests
  • Stool Tests
• Imaging Tests
  • CT Scan or X-ray
  • Upper Endoscopy
  • Upper Endoscopy

By Indication

• Pain and Cramping
• Diarrhea
• Constipation
• Alternating Constipation & Diarrhea

By Country

• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East and Africa

Company Profiles

• Commonwealth Diagnostics International
• Genova Diagnostics
• Inova Diagnostics, Inc
• Biohit Oyj
• Aerodiagnostics, LLC.
• Sysmex Corporation (Sysmex Europe GmbH)
• BÜHLMANN Laboratories AG